Studies suggest these products can achieve similar replenishment when total iron doses are matched, so the real
question is usually not which brand is universally "best." The better question is which formulation makes the
most sense for the patient, the care setting, and the safety margin required for treatment at home.
The Five Common IV Iron Formulations
All five options below can restore iron stores. The biggest differences are how much iron can be given per
visit, how many visits are usually needed, how comfortable the product is in a non-hospital setting, and how
much treatment typically costs for self-pay patients.
Safety-forward starting point
Iron Sucrose (Venofer)
One of the most widely used IV iron options across outpatient infusion centers, obstetrics, dialysis,
and general medical practice.
Strengths
- Excellent safety record with a low rate of severe reactions
- Well tolerated across diverse patient populations
- Predictable improvements in iron and hemoglobin levels
- Flexible dosing makes staged repletion easier to schedule
Tradeoffs
- Usually requires multiple infusions, often 3-5 visits
- Less convenient for people trying to complete treatment in one session
Typical cash-pay range: $300-$600 per infusion (100-200 mg).
Relative cost: Baseline reference point for comparison.
Lower-dose alternative
Sodium Ferric Gluconate (Ferrlecit)
A long-standing formulation still used most often in dialysis care and other chronic medical settings.
Strengths
- Long-established safety history
- Generally well tolerated
- Effective for gradual iron repletion
Tradeoffs
- Smaller dose per infusion, typically 125 mg
- Requires multiple visits and is used less often outside nephrology contexts
Typical cash-pay range: $500-$900 per infusion (125 mg).
Relative cost: Often around 1.5-2x the cost of Venofer per mg delivered.
Single-visit repletion option
Low-Molecular-Weight Iron Dextran (INFeD)
Distinct because it can be given as a total-dose infusion, potentially replacing the full iron deficit
in one visit.
Strengths
- Can deliver 1,000 mg or more in one session
- Useful when rapid, one-visit repletion is the priority
Tradeoffs
- Higher hypersensitivity risk than iron sucrose or ferric gluconate
- Historically required a test dose
- Usually not the first choice for home infusion
Typical cash-pay range: $900-$1,600 per infusion (usually 500-1,000 mg).
Relative cost: Often lands near the total cost of a full Venofer series.
Rapid dosing, higher cost
Ferumoxytol (Feraheme)
A newer formulation built around convenience, commonly given as two 510 mg infusions.
Strengths
- Convenient dosing schedule with fewer visits
- Rapid improvements in iron indices and hemoglobin
- Can be useful when time to repletion matters
Tradeoffs
- Higher risk of hypersensitivity or anaphylaxis than iron sucrose and ferric gluconate
- Includes an FDA boxed warning
- Very expensive for cash-pay treatment and harder to justify for home infusion
Typical cash-pay range: $2,000-$3,500 per infusion (510 mg); many patients need two doses.
Relative cost: Often 5-10x the cost of completing a full Venofer series.
High-dose convenience option
Ferric Carboxymaltose (Injectafer / Ferinject)
A higher-dose formulation frequently given as two 750 mg infusions.
Strengths
- Efficient repletion in 1-2 visits
- Widely studied internationally
- Useful when faster dosing is clinically appropriate
Tradeoffs
- Higher rates of hypophosphatemia than iron sucrose
- High self-pay cost
- Less attractive for home infusion because the convenience gain may not outweigh the added expense and monitoring considerations
Typical cash-pay range: $1,800-$3,000 per infusion (750 mg); a full course is often two doses.
Relative cost: Often 5-8x the cost of a full Venofer series.
How to Interpret the Comparison
- Total dose matters more than brand name when the goal is replenishing iron stores.
- Fewer visits can sound attractive, but higher-dose products may bring higher reaction risk, higher cost, or both.
- The safest choice in a hospital or infusion center is not automatically the best choice for a home setting.
- Kidney disease, pregnancy context, prior reactions, urgency, and access to monitoring all influence which product is reasonable.
- Cash-pay pricing varies with dose, pharmacy sourcing, monitoring time, and whether the quote covers a full treatment course or a single visit.
What the Research Shows: Similar Efficacy Across Formulations
- Modern IV iron formulations replenish iron stores effectively when equivalent doses are used.[1][2]
- Hemoglobin improvements are broadly similar across products in head-to-head comparisons.[1][3]
- Serious adverse events are rare overall, but the risk profile is not identical across formulations.[4][5]
- Because efficacy is often comparable, clinicians usually focus on safety, cost, convenience, and infusion setting when selecting a product.[6]
That is why there is no single IV iron product that wins in every situation. Formulation choice is usually a
practical decision made after the diagnosis, setting, and risk tolerance are clear.
Why Venofer Is Often the Best Fit for Home Infusion
Home infusion raises the bar for predictability. The best home option is not simply the product that delivers
the most iron in the fewest visits. It is the product that balances reliable repletion with a conservative
reaction profile and a cost structure patients can realistically complete.
- Lower reaction burden: Iron sucrose has one of the more reassuring safety profiles among modern IV iron products.[4]
- More accessible pricing: Typical cash-pay pricing is materially lower than the higher-dose branded alternatives.
- Comparable outcomes: When total doses are matched, Venofer can replenish iron and improve hemoglobin as effectively as more expensive options.[1][2][3]
- Better fit for at-home monitoring: Gradual dosing and established protocols make it easier to manage safely outside a hospital or infusion suite.
- Practical completion path: A series that is affordable and well tolerated is often more realistic than a shorter course that carries higher cost or risk.
For those reasons, Venofer is often the most practical first-line option when an NP and RN team is designing a
home-based iron infusion plan.
Before You Compare Formulations, Confirm the Basics
The product discussion only matters after recent labs confirm that IV iron is appropriate. A current CBC,
ferritin, and iron panel help determine whether the problem is truly iron deficiency, how severe it is, and how
urgent repletion needs to be. If you still need that workup, our Iron &
Fatigue Panel outlines one common starting point for at-home lab review.
The infusion setting matters too. Home IV iron should involve clinician oversight, RN monitoring, and a clear
reaction plan. If you are comparing mobile providers, our guide on choosing a safe IV provider
can help you vet the basics. If low iron entered the conversation through fatigue, heavy cycles, or midlife
cognitive symptoms, our article on iron and
menopause-related brain fog adds useful context for that discussion.
Need help deciding whether home IV iron makes sense?
We review current labs, symptom timing, reaction history, and treatment setting to help determine
whether home IV iron is appropriate and which formulation fits best.
Conclusion
All five IV iron formulations can work when they are dosed appropriately, but they differ in meaningful ways
on reaction profile, number of visits, and cash-pay cost. For home infusion, iron sucrose (Venofer) often
offers the most balanced mix of safety, predictability, and affordability.
If your labs confirm iron deficiency or iron-deficiency anemia, the safest next step is to work with a
clinician who can match the formulation to your history, your urgency, and the setting where treatment will be
delivered.
Ready to request an iron infusion consult?
We can review your labs, confirm whether IV iron is appropriate, and coordinate an NP-prescribed,
RN-delivered visit at home, in the office, or at your hotel when it is a good fit.
